Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (26)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Gressani, K. M.
Right arrow Articles by Miller, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gressani, K. M.
Right arrow Articles by Miller, M. S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol 19, 1045-1052, Copyright © 1998 by Oxford University Press


ARTICLES

Induction of mutations in Ki-ras and INK4a in liver tumors of mice exposed in utero to 3-methylcholanthrene

KM Gressani, LA Rollins, S Leone-Kabler, JM Cline and MS Miller
Department of Physiology and Pharmacology, Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.

An understanding of the basic mechanisms responsible for the pathogenesis of liver neoplasms is needed in order to develop better therapeutic strategies. The present study utilized a pharmacogenetic mouse model to assess the role of cytochrome P4501A1 (Cyp1a1) in modulating genetic damage to oncogenic and tumor suppressor loci following in utero exposure to the polycyclic aromatic hydrocarbon, 3- methylcholanthrene (MC). Analysis of the Ha-ras, Ki-ras, INK4a and p53 genes was carried out with lysates from paraffin-embedded liver tissue from transplacentally-treated mice. The lysates were subjected to DNA amplification by the PCR technique followed by allele-specific oligonucleotide hybridization screening and SSCP analysis. All of the 26 neoplasms screened (23 hepatocellular carcinomas, two hepatocellular adenomas and one sarcoma) exhibited a GGC-->CGC (GLY13-->ARG13) transversion at the Ki-ras gene locus. None of the tumors had Ki-ras mutations at codon 12 of exon 1. Approximately 12% (3/26) of the liver tumors exhibited point mutations in exon 1 of the INK4a gene, with each of the three tumors exhibiting two point mutations. Analysis of exon 2 of the INK4a gene showed the presence of a CCG-->CTG (PRO73-->LEU73) transition in two of the 26 neoplasms. No mutations were found in exons 1 or 2 of the Ha-ras gene, or in exons 5-8 of the p53 gene. Analysis of tumor RNAs showed overexpression of Ha-ras, cip1 and c-jun in approximately 38% of the liver tumor samples. The results of this study suggest that mutagenic damage to oncogenes and tumor suppressor genes may be critical factors in mediating transplacentally-induced liver tumorigenesis. The fact that Ki-ras mutations were found in all of the tumors suggests that mutation at this gene locus may be an early event in liver tumor pathogenesis, while mutation in tumor suppressor genes may occur later during tumor progression. These combined results are consistent with the pathogenesis of cancer in humans.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
Z. Yu, C. V. Loehr, K. A. Fischer, M. A. Louderback, S. K. Krueger, R. H. Dashwood, N. I. Kerkvliet, C. B. Pereira, J. E. Jennings-Gee, S. T. Dance, et al.
In utero Exposure of Mice to Dibenzo[a,l]Pyrene Produces Lymphoma in the Offspring: Role of the Aryl Hydrocarbon Receptor
Cancer Res., January 15, 2006; 66(2): 755 - 762.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. K. Sharma, B. A. Zehnbauer, M. A. Watson, and D. H. Gutmann
RAS pathway activation and an oncogenic RAS mutation in sporadic pilocytic astrocytoma
Neurology, October 25, 2005; 65(8): 1335 - 1336.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
B. Govindarajan, M. C. Mizesko, M. S. Miller, H. Onda, M. Nunnelly, K. Casper, D. Brat, C. Cohen, and J. L Arbiser
Tuberous Sclerosis-associated Neoplasms Express Activated p42/44 Mitogen-activated Protein (MAP) Kinase, and Inhibition of MAP Kinase Signaling Results in Decreased in Vivo Tumor Growth
Clin. Cancer Res., August 1, 2003; 9(9): 3469 - 3475.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. M. Strickland, S. Pathak, A. S. Multani, R. P. Pelley, and C. K. Donawho
Molecular Characterization of New Melanoma Cell Lines from C3H Mice Induced by Ethanol plus Ultraviolet Radiation
Cancer Res., July 1, 2003; 63(13): 3503 - 3510.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. Takagi, T. Matsuzaki, M. Sato, K. Nomoto, M. Morotomi, and T. Yokokura
Enhancement of natural killer cytotoxicity delayed murine carcinogenesis by a probiotic microorganism
Carcinogenesis, April 1, 2001; 22(4): 599 - 605.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
L. Zhang, D. L. Weddle, P. E. Thomas, B. Zheng, A. Castonguay, H. M. Schuller, and M. S. Miller
Low Levels of Expression of Cytochromes P-450 in Normal and Cancerous Fetal Pancreatic Tissues of Hamsters Treated with NNK and/or Ethanol
Toxicol. Sci., August 1, 2000; 56(2): 313 - 323.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Serrano
The INK4a/ARF locus in murine tumorigenesis
Carcinogenesis, May 1, 2000; 21(5): 865 - 869.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Frey, A. Buchmann, W. Bursch, R. Schulte-Hermann, and M. Schwarz
Suppression of apoptosis in C3H mouse liver tumors by activated Ha-ras oncogene
Carcinogenesis, February 1, 2000; 21(2): 161 - 166.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. M. Gressani, S. Leone-Kabler, M.G. O'Sullivan, L.D. Case, A. M. Malkinson, and M. S. Miller
Strain-dependent lung tumor formation in mice transplacentally exposed to 3-methylcholanthrene and post-natally exposed to butylated hydroxytoluene
Carcinogenesis, November 1, 1999; 20(11): 2159 - 2165.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.